JP2008509672A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509672A5
JP2008509672A5 JP2007525816A JP2007525816A JP2008509672A5 JP 2008509672 A5 JP2008509672 A5 JP 2008509672A5 JP 2007525816 A JP2007525816 A JP 2007525816A JP 2007525816 A JP2007525816 A JP 2007525816A JP 2008509672 A5 JP2008509672 A5 JP 2008509672A5
Authority
JP
Japan
Prior art keywords
tshr
mrna
nucleic acid
acid sample
segment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525816A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509672A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028688 external-priority patent/WO2006020837A2/en
Publication of JP2008509672A publication Critical patent/JP2008509672A/ja
Publication of JP2008509672A5 publication Critical patent/JP2008509672A5/ja
Pending legal-status Critical Current

Links

JP2007525816A 2004-08-11 2005-08-11 甲状腺癌の検出方法 Pending JP2008509672A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60058904P 2004-08-11 2004-08-11
PCT/US2005/028688 WO2006020837A2 (en) 2004-08-11 2005-08-11 Method of detecting thyroid cancer

Publications (2)

Publication Number Publication Date
JP2008509672A JP2008509672A (ja) 2008-04-03
JP2008509672A5 true JP2008509672A5 (enExample) 2008-09-04

Family

ID=35908168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525816A Pending JP2008509672A (ja) 2004-08-11 2005-08-11 甲状腺癌の検出方法

Country Status (8)

Country Link
US (1) US20070065833A1 (enExample)
EP (1) EP1778872A2 (enExample)
JP (1) JP2008509672A (enExample)
KR (1) KR20070044048A (enExample)
AU (2) AU2005272696A1 (enExample)
BR (1) BRPI0514265A (enExample)
CA (1) CA2576912A1 (enExample)
WO (1) WO2006020837A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
US8394580B2 (en) * 2007-08-17 2013-03-12 The Johns Hopkins University Protein markers for the detection of thyroid cancer metastasis
CA2725978A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
EP3831954A3 (en) 2008-11-17 2021-10-13 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
EP3360978A3 (en) 2009-05-07 2018-09-26 Veracyte, Inc. Methods for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US20110312520A1 (en) 2010-05-11 2011-12-22 Veracyte, Inc. Methods and compositions for diagnosing conditions
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
EP2791359B1 (en) 2011-12-13 2020-01-15 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
ES3015226T3 (en) 2012-08-16 2025-04-30 Veracyte Sd Inc Prostate cancer prognosis using biomarkers
BR112015022490A2 (pt) 2013-03-15 2017-07-18 Veracyte Inc métodos e composições para classificação de amostras
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
CN114606309A (zh) 2014-11-05 2022-06-10 威拉赛特公司 使用机器学习和高维转录数据的诊断系统和方法
CN113082201B (zh) 2016-04-01 2024-07-05 上海斯丹赛生物技术有限公司 刺激t细胞介导的对表达抗原的细胞群的免疫应答的方法
US10654934B2 (en) 2016-04-01 2020-05-19 Innovative Cellular Therapeutics CO., LTD. Use of chimeric antigen receptor modified cells to treat cancer
EP3504348B1 (en) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
WO2018132916A1 (en) 2017-01-20 2018-07-26 Genomedx Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
AU2018230784A1 (en) 2017-03-09 2019-10-10 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
WO2018205035A1 (en) 2017-05-12 2018-11-15 Genomedx Biosciences, Inc Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
WO2019028285A2 (en) 2017-08-04 2019-02-07 Genomedx, Inc. USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY
CN108089011A (zh) * 2018-01-09 2018-05-29 广州市康润生物科技有限公司 一种快速免疫检测系统在手术中的新用途
KR102745894B1 (ko) * 2019-04-05 2024-12-23 주식회사 제놉시 Cfdna를 이용한 방광암 진단방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391579B1 (en) * 1996-02-01 2002-05-21 Albert Einstein College Of Medicine Of Yeshiva University Thyroid sodium/iodide symporter and nucleic acid encoding same
US6066449A (en) * 1997-04-15 2000-05-23 The Trustees Of Columbia University In The City Of New York Method of detecting metastatic thyroid cancer
WO1998056953A1 (en) * 1997-06-10 1998-12-17 Johns Hopkins University School Of Medicine Methods for thyroid cell detection
US20020009778A1 (en) * 1998-05-29 2002-01-24 Incyte Pharmaceuticals, Inc. Thyroid and pituitary membrane protein
US6436642B1 (en) * 1999-04-20 2002-08-20 Curagen Corporation Method of classifying a thyroid carcinoma using differential gene expression

Similar Documents

Publication Publication Date Title
Carrascosa et al. Molecular inversion probe-based SPR biosensing for specific, label-free and real-time detection of regional DNA methylation
Duan et al. An ssDNA library immobilized SELEX technique for selection of an aptamer against ractopamine
JP2007536260A5 (enExample)
JP2009536525A5 (enExample)
JP2010532986A5 (enExample)
Tu et al. Fluorescence quenching of graphene oxide integrating with the site-specific cleavage of the endonuclease for sensitive and selective microRNA detection
JP2019528063A5 (enExample)
JP2008245635A5 (enExample)
JP2009509508A5 (enExample)
JP2010535219A5 (enExample)
JP2009523005A5 (enExample)
JP2009077712A5 (enExample)
JP2008249727A5 (enExample)
ATE329060T1 (de) Mrna amplifizierung
Giamblanco et al. Single-step label-free hepatitis B virus detection by a piezoelectric biosensor
JP2012513216A5 (enExample)
JP2019520802A5 (enExample)
Xie et al. CRISPR-Cas12a coupled with DNA nanosheet-amplified fluorescence anisotropy for sensitive detection of biomolecules
JP2008510454A5 (enExample)
WO2009074882A3 (en) One-step target detection assay using a tagged and blocked target-specific pcr primer and an anti-tag capture complex
Umer et al. A novel DNA binding protein-based platform for electrochemical detection of miRNA
YU48903A (sh) Sistem probe sa potapajućom test trakom i postupak sa probom za detekciju i/ili određivanje specifičnih sekvenci nukleinske kiseline
JP2007523644A5 (enExample)
WO2007066831A3 (en) Method of detecting human papilloma virus by using nucleic acid amplification method and nucleic acid chain-immobilized carrier
WO2009061640A3 (en) Hepatitis b virus (hbv) specific oligonucleotide sequences